Alnylam Pharmaceuticals | ALNY - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
BioMarin Pharmaceutical 15.28 3.96 2026-03
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 28.09 807.38 2026-03
Novartis 17.79 1.74 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-12
Takeda 46.52 188.53 2026-03
Tectonic Therapeutic 4.01 0.63 2024-03
Vertex Pharmaceuticals 25.82 0.33 2026-03
Xencor 29.92 3.22 2022-09